Identification of first-in-class, orally bioavailable SOS1 bifunctional degraders for the treatment of KRAS- and RTK-driven cancers

BTX-10908 - BioTheryX

K. Begovich; A. Schoolmeesters; N. Rajapakse; E. Martinez; Q. Liu; A. Shakya; A. Okano; V. Mali; S. Huang; A. Chourasia; L. Fung

Mar 6, 2024